DICE Therapeutics Announces Pricing of Upsized Initial Public Offering
SOUTH SAN FRANCISCO, Calif., Sept. 14, 2021 (GLOBE NEWSWIRE) — DICE Therapeutics, Inc. (Nasdaq: DICE),…
Month: September 2021
PROCEPT BioRobotics Corporation Announces Pricing of Upsized Initial Public Offering
REDWOOD CITY, Calif., Sept. 14, 2021 (GLOBE NEWSWIRE) — PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (“PROCEPT”),…
Syneos Health Acquires StudyKIK
Acquisition Offers Sites and Sponsors Access to Technology-Enabled, Insight-Powered Solutions, Accelerating Clinical Trial Recruitment, Retention…
Checkmate Pharmaceuticals to Present at the Cantor Virtual Global Healthcare Conference
CAMBRIDGE, Mass., Sept. 14, 2021 (GLOBE NEWSWIRE) — Checkmate Pharmaceuticals Inc. (NASDAQ: CMPI) (“Checkmate”), a…
Travere Therapeutics Appoints Ruth Williams-Brinkley to its Board of Directors
Ms. Williams-Brinkley brings more than 35 years of executive leadership experience in healthcare to the…
Avalo Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
WAYNE, Pa. and ROCKVILLE, Md., Sept. 14, 2021 (GLOBE NEWSWIRE) — Avalo Therapeutics, Inc. (“Avalo”…
AB Science announced that it has received new authorizations to resume patient enrollment in its Phase 3 studies of masitinib
PRESS RELEASE AB SCIENCE ANNOUNCES THAT IT HAS RECEIVED NEW AUTHORIZATIONS TO RESUME PATIENT ENROLLMENT…
GBT Establishes The GBT Foundation to Improve the Health and Well-being of Underserved Patient Communities Around the World
SOUTH SAN FRANCISCO, Calif., Sept. 14, 2021 (GLOBE NEWSWIRE) — Global Blood Therapeutics, Inc. (GBT) (NASDAQ:…
Accelus Announces Addition of TiHawk9™ Titanium-Bonded Multidirectional Implant to its FlareHawk® Family of Expandable Interbody Fusion Cages
TiHawk blends features of PEEK with titanium for a modulus more similar to bone that…
UPDATE — Axiom Presents “Rare Disease Studies – Using technology to expand the opportunities of enrollment” at Clinical Trials in Rare Diseases Conference 2021
TORONTO, Sept. 14, 2021 (GLOBE NEWSWIRE) — Axiom Real-Time Metrics (“Axiom”), a premier provider of…
T2 Biosystems to Unveil New Data at September Conferences
Leading rapid diagnostics company to share new research at industry conferences throughout Sepsis Awareness Month LEXINGTON,…
Sanofi completes acquisition of Translate Bio, accelerating the application of mRNA in new vaccines and therapeutics
Sanofi completes acquisition of Translate Bio, accelerating the application of mRNA in new vaccines and…
Scopus BioPharma’s Subsidiary — Duet Therapeutics — Announces Appointments of John Rossi, Ph.D. and Nagy Habib, Ch.M., F.R.C.S. to the Scientific Advisory Board
Dr. Rossi is a world leader in the development of RNA interference, the Lidow Family…
Skye Bioscience Announces Special Virtual Investor Presentation
Skye Bioscience Investor Hour Please join us for a special investor presentation. SAN DIEGO, CA,…
Nkarta to Participate at Upcoming Investor Conference
SOUTH SAN FRANCISCO, Calif., Sept. 14, 2021 (GLOBE NEWSWIRE) — Nkarta, Inc. (Nasdaq: NKTX), a…
Published Study Shows Healthy Extracts Breakthrough Nutraceutical Formulation, ACTIVATE, Naturally Enhances Key Brain Activity by 46%
UBN ACTIVATE™ UBN ACTIVATE™ is clinically proven to enhance brain function, improve cognition, memory, focus,…
Acasti Pharma to Present at the Oppenheimer Fall Healthcare Summit on September 21ˢᵗ
LAVAL, Québec, Sept. 14, 2021 (GLOBE NEWSWIRE) — Acasti Pharma Inc. (“Acasti” or the “Company”)…
SELLAS Life Sciences to Present at the 2021 Cantor Virtual Global Healthcare Conference on September 28th
NEW YORK, Sept. 14, 2021 (GLOBE NEWSWIRE) — SELLAS Life Sciences Group, Inc. (NASDAQ: SLS)…
Vallon Pharmaceuticals Announces Formation of Scientific Advisory Board
– Inaugural appointments include globally renowned leaders and experts on attention-deficit/hyperactivity disorder (ADHD) and stimulant…
Perception Neuroscience initiates Phase 2a study of PCN-101 (R-ketamine) for treatment resistant depression
NEW YORK and BERLIN, Sept. 14, 2021 (GLOBE NEWSWIRE) — Perception Neuroscience (Perception), an atai…